(By Yusuff Moshood)
Drugfield Pharmaceuticals is committed to providing products that will help improve the health of Nigerians, Pharm. Michael Odediran has said.
Odediran, who is the general manager (sales and marketing) for Drugfield, while speaking in an exclusive interview with Pharmanews in his office in Sango Ota, recently, noted that it is the desire to fulfil this sacred commitment that propels the company to constantly introduce new and beneficial products into the Nigerian pharmaceutical market.
According to him, it was the same motivation that prompted the company to introduce its own intravenous fluid products (infusion products) into the market last year, adding thatthe company also introduced Coflax with codeine,a cough syrup with codeine; Drupidox, a brand of sulfadoxine/pyrimethamine antimalarial, as well as Tramadol, a controlled analgesic.
Odediran stated further that, in keeping with the company’s vision, Drugfield would introduce other equally beneficial products into the market in 2014.Some of the scheduled products include:Betadone-N eye ointment, which is an addition to the Betadone-N eye/ear drops; and Chlorxy-G gel which will be a special product for neonates healthcare.
Drugfield, he added, also intends to increase its range of antihypertensives to further help Nigerians living with hypertension.
Odediran expressed his appreciation for the support of Drugfield customers and partner institutions in 2013, adding that the company was counting on their continued support and cooperation for better performance in 2014.
On the challenge of drug counterfeiting in Nigeria, Pharm. Odediran noted that the company relentlessly battled the perpetrators last year, adding that aside improving collaboration with other companies and institutions to fight drug fakers, Drugfield had also established a unit mandated to keep tracks of its products in the market to protect them from drug fakers.